{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T04:45:37Z","timestamp":1776401137813,"version":"3.51.2"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T00:00:00Z","timestamp":1669680000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004621","name":"Kerman University of Medical Sciences","doi-asserted-by":"publisher","award":["98000240"],"award-info":[{"award-number":["98000240"]}],"id":[{"id":"10.13039\/501100004621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ijpddr.2022.11.006","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T13:38:29Z","timestamp":1670247509000},"page":"21-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Poor adherence is a major barrier to the proper treatment of cutaneous leishmaniasis: A case-control field assessment in Iran"],"prefix":"10.1016","volume":"21","author":[{"given":"Mehdi","family":"Bamorovat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iraj","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Setareh","family":"Agha Kuchak Afshari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Karamoozian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amirhossein","family":"Tahmouresi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amireh","family":"Heshmatkhah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehsan","family":"Salarkia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Khosravi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Hakimi Parizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Barghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ijpddr.2022.11.006_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007423","article-title":"Associated-risk determinants for anthroponotic cutaneous leishmaniasis treated with meglumine antimoniate: a cohort study in Iran","volume":"13","author":"Aflatoonian","year":"2019","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"1\u20132","key":"10.1016\/j.ijpddr.2022.11.006_bib2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.26719\/2003.9.1-2.99","article-title":"Patterns of belief and use of traditional remedies by diabetic patients in Mecca, Saudi Arabia","volume":"9","author":"Al Saeedi","year":"2003","journal-title":"EMHJ Eastern Mediterr. Heal. J."},{"key":"10.1016\/j.ijpddr.2022.11.006_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpddr.2022.11.006_bib4","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1046\/j.1365-3156.2001.00740.x","article-title":"Improving adherence to malaria treatment for children: the use of pre\u2010packed chloroquine tablets vs. chloroquine syrup","volume":"6","author":"Ansah","year":"2001","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.ijpddr.2022.11.006_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005739","article-title":"A new perspective on cutaneous leishmaniasis\u2014implications for global prevalence and burden of disease estimates","volume":"11","author":"Bailey","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2022.11.006_bib6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.intimp.2019.02.008","article-title":"Host's immune response in unresponsive and responsive patients with anthroponotic cutaneous leishmaniasis treated by meglumine antimoniate: a case-control study of Th1 and Th2 pathways","volume":"69","author":"Bamorovat","year":"2019","journal-title":"Int. Immunopharm."},{"issue":"2","key":"10.1016\/j.ijpddr.2022.11.006_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192236","article-title":"Risk factors for anthroponotic cutaneous leishmaniasis in unresponsive and responsive patients in a major focus, southeast of Iran","volume":"13","author":"Bamorovat","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpddr.2022.11.006_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009089","article-title":"Major risk factors and histopathological profile of treatment failure, relapse and chronic patients with anthroponotic cutaneous leishmaniasis: a prospective case-control study on treatment outcome and their medical importance","volume":"15","author":"Bamorovat","year":"2021","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2022.11.006_bib9","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.3389\/fmicb.2021.638957","article-title":"Determinants of unresponsiveness to treatment in cutaneous leishmaniasis: a focus on anthroponotic form due to Leishmania tropica","volume":"12","author":"Bamorovat","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ijpddr.2022.11.006_bib10","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00002030-200003100-00008","article-title":"Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population","volume":"14","author":"Bangsberg","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.ijpddr.2022.11.006_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005515","article-title":"Risk factors for therapeutic failure to meglumine antimoniate and miltefosine in adults and children with cutaneous leishmaniasis in Colombia: a cohort study","volume":"11","author":"Castro","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2022.11.006_bib12","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/09540120050042891","article-title":"Patient care committee & adherence working group of the outcomes committee of the adult AIDS clinical trials group (AACTG). Self-Reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments","volume":"12","author":"Chesney","year":"2000","journal-title":"AIDS Care"},{"key":"10.1016\/j.ijpddr.2022.11.006_bib13","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jdeveco.2018.04.008","article-title":"The impact of packaging and messaging on adherence to malaria treatment: evidence from a randomized controlled trial in Uganda","volume":"134","author":"Cohen","year":"2018","journal-title":"J. Dev. Econ."},{"key":"10.1016\/j.ijpddr.2022.11.006_bib14","series-title":"Managing Chronic Illness: A Biopsychosocial Perspective","first-page":"313","article-title":"Clinical assessment and management of adherence to medical regimens","author":"Dunbar-Jacob","year":"1995"},{"key":"10.1016\/j.ijpddr.2022.11.006_bib15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1891\/0739-6686.18.1.48","article-title":"Adherence in chronic disease","volume":"18","author":"Dunbar-Jacob","year":"2000","journal-title":"Annu. Rev. Nurs. Res."},{"key":"10.1016\/j.ijpddr.2022.11.006_bib16","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/S0149-2918(99)80026-5","article-title":"Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice","volume":"21","author":"Farmer","year":"1999","journal-title":"Clin. Therapeut."},{"key":"10.1016\/j.ijpddr.2022.11.006_bib17","article-title":"Old world cutaneous leishmaniasis in Iran: clinical variants and treatments","volume":"1\u201311","author":"Firooz","year":"2020","journal-title":"J. Dermatol. Treat."},{"key":"10.1016\/j.ijpddr.2022.11.006_bib18","doi-asserted-by":"crossref","first-page":"e162","DOI":"10.1371\/journal.pmed.0030162","article-title":"Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites","volume":"3","author":"Hadighi","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.ijpddr.2022.11.006_bib19","series-title":"Cochrane Database Syst. Rev","article-title":"Interventions for helping patients to follow prescriptions for medications","author":"Haynes","year":"2002"},{"issue":"6","key":"10.1016\/j.ijpddr.2022.11.006_bib20","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0022-3999(99)00058-6","article-title":"Patients' beliefs about treatment: the hidden determinant of treatment outcome?","volume":"47","author":"Horne","year":"1999","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.ijpddr.2022.11.006_bib21","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0022-3999(99)00057-4","article-title":"Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness","volume":"47","author":"Horne","year":"1999","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.ijpddr.2022.11.006_bib22","first-page":"156","article-title":"The efficacy, relapse and failure in the treatment of anthroponotic cutaneous leishmaniosis with intralesional Glucantime along with cryotherapy","volume":"23","author":"Karvar","year":"2016","journal-title":"J. Kerman Univ. Med. Sci."},{"key":"10.1016\/j.ijpddr.2022.11.006_bib23","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1016\/j.vaccine.2005.02.015","article-title":"Leishmanization: use of an old method for evaluation of candidate vaccines against leishmaniasis","volume":"23","author":"Khamesipour","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.ijpddr.2022.11.006_bib24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000083797","article-title":"Cutaneous leishmaniasis caused by Leishmania tropica: treatment with oral fluconazole","volume":"210","author":"Laffitte","year":"2005","journal-title":"Dermatology"},{"key":"10.1016\/j.ijpddr.2022.11.006_bib25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/09540120020018161","article-title":"Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA","volume":"13","author":"Murphy","year":"2001","journal-title":"AIDS Care"},{"key":"10.1016\/j.ijpddr.2022.11.006_bib26","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.ijantimicag.2007.01.004","article-title":"Leishmania spp.: proficiency of drug-resistant parasites","volume":"29","author":"Natera","year":"2007","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ijpddr.2022.11.006_bib27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.drup.2004.07.002","article-title":"Leishmaniasis: drugs in the clinic, resistance and new developments","volume":"7","author":"Ouellette","year":"2004","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.ijpddr.2022.11.006_bib28","doi-asserted-by":"crossref","first-page":"625","DOI":"10.7326\/0003-4819-134-7-200104030-00020","article-title":"Adherence to protease inhibitors","volume":"134","author":"Paterson","year":"2001","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijpddr.2022.11.006_bib29","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.socscimed.2012.04.038","article-title":"Cruel disease, cruel medicine: self-treatment of cutaneous leishmaniasis with harmful chemical substances in Suriname","volume":"75","author":"Ramdas","year":"2012","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.ijpddr.2022.11.006_bib30","first-page":"42","article-title":"Hypertension: catch them when they\u2019re older","author":"Richardson","year":"2000","journal-title":"Nurs. Times"},{"key":"10.1016\/j.ijpddr.2022.11.006_bib31","first-page":"243","article-title":"Family caregiving: who provides the care, and at what cost?","volume":"15","author":"Robinson","year":"1997","journal-title":"Nurs. Econ."},{"issue":"2","key":"10.1016\/j.ijpddr.2022.11.006_bib32","article-title":"Factors associated with treatmet failure of cutaneous leishmaniasis with meglumine antimoniate","volume":"39","author":"Rodrigues","year":"2006","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.ijpddr.2022.11.006_bib33","article-title":"A newly emerged cutaneous leishmaniasis focus in central Iran","volume":"17","author":"Rostami","year":"2013","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2022.11.006_bib34","first-page":"63","article-title":"Improving cardiovascular health in postmenopausal women by addressing medication adherence issues","volume":"42","author":"Rybacki","year":"2002","journal-title":"J. Am. Pharmaceut. Assoc."},{"key":"10.1016\/j.ijpddr.2022.11.006_bib35","first-page":"48","article-title":"Outbreak of zoonotic cutaneous leishmaniasis: a report","volume":"2","author":"Saghafipour","year":"2013","journal-title":"Arch. Hyg. Sci."},{"key":"10.1016\/j.ijpddr.2022.11.006_bib36","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1590\/S0080-62341998000400007","article-title":"Compliance in antihypertensive therapy: analyses in scientific articles","volume":"32","author":"Sarquis","year":"1998","journal-title":"Rev. Esc. Enferm. USP"},{"key":"10.1016\/j.ijpddr.2022.11.006_bib37","first-page":"299","article-title":"A comprehensive review of cutaneous leishmaniasis in Kerman Province, Southeastern Iran-narrative review article","volume":"44","author":"Sharifi","year":"2015","journal-title":"Iran J."},{"key":"10.1016\/j.ijpddr.2022.11.006_bib38","doi-asserted-by":"crossref","DOI":"10.26719\/2015.21.10.736","article-title":"Epidemiological status of leishmaniasis in the Islamic Republic of Iran, 1983-2012","volume":"21","author":"Shirzadi","year":"2015","journal-title":"East. Mediterr. Health J."},{"key":"10.1016\/j.ijpddr.2022.11.006_bib39","series-title":"Minist. Heal. Med. Educ. (MOH). Zoonoses Control Dep","first-page":"1","article-title":"National Guidelines for cutaneous leishmaniasis surveillance in Iran","author":"Shirzadi","year":"2012"},{"issue":"4","key":"10.1016\/j.ijpddr.2022.11.006_bib40","first-page":"63","article-title":"Smoking cessation: clinical steps to improve compliance","volume":"48","author":"Timmreck","year":"1993","journal-title":"Geriatrics"},{"key":"10.1016\/j.ijpddr.2022.11.006_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-019-4293-8","article-title":"Retention in care and adherence to HIV and AIDS treatment in Anambra State Nigeria","volume":"19","author":"Umeokonkwo","year":"2019","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.ijpddr.2022.11.006_bib42","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/tmi.12025","article-title":"Adherence to miltefosine treatment for visceral leishmaniasis under routine conditions in Nepal","volume":"18","author":"Uranw","year":"2013","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.ijpddr.2022.11.006_bib43","series-title":"Global Health Observatory Data Repository: Number of Cases of Cutaneous Leishmaniasis Reported","year":"2017"},{"key":"10.1016\/j.ijpddr.2022.11.006_bib44","series-title":"Leishmaniasis, Status of endemicity of cutaneous leishmaniasis: 2019. 2020\u201306\u201315","year":"2019"},{"key":"10.1016\/j.ijpddr.2022.11.006_bib46","series-title":"Manual for Case Management of Cutaneous Leishmaniasis in the WHO Eastern Mediterranean Region","year":"2014"},{"key":"10.1016\/j.ijpddr.2022.11.006_bib47","series-title":"Adherence to Long-Term Therapies : Evidence for Action","year":"2003"}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320722000331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320722000331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:52:55Z","timestamp":1761922375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320722000331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":46,"alternative-id":["S2211320722000331"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2022.11.006","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Poor adherence is a major barrier to the proper treatment of cutaneous leishmaniasis: A case-control field assessment in Iran","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2022.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}]}}